Visiting fellow Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J8-55
- knies@eshpm.eur.nl
More information
‹ Back to overview
Profile
- Joost J. Enzing, Sebastian Himmler, Saskia Knies & Werner B.F. Brouwer (2021) - Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? - Value in Health - doi: 10.1016/j.jval.2021.08.007
- Joost Enzing, SMC Vijgen, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review - Health Policy and Technology - doi: 10.1016/j.hlpt.2020.09.006 - [link]
- Joost Enzing, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? - Health Economics, Policy and Law - doi: 10.1017/S1744133120000237 - [link]
- RA Vreman, JW Geenen, Saskia Knies, AK Mantel-Teeuwisse, HGM Leufkens & WG Goettsch (2020) - The Application and Implications of Novel Deterministic Sensitivity Analysis Methods. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-020-00979-3
- C Rothery, M Strong, HE Koffijberg, A Basu, S Ghabri, Saskia Knies, JF Murray, GD Sanders Schmidler, L Steuten & E Fenwick (2020) - Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (3), 277-286 - doi: 10.1016/j.jval.2020.01.004
- E Fenwick, L Steuten, Saskia Knies, S Ghabri, A Basu, JF Murray, HE Koffijberg, M Strong, GD Sanders Schmidler & C Rothery (2020) - Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (2), 139-150 - doi: 10.1016/j.jval.2020.01.001.
- SE Grimm, X Pouwels, BLT Ramaekers, B Wijnen, Saskia Knies, J Grutters & MA Joore (2019) - Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-019-00855-9.
- Saskia Knies, Hans Severens & Werner Brouwer (2019) - Integrating clinical and economic evidence in clinical guidelines: More needed than ever! - Journal of Evaluation in Clinical Practice, 25 (4), 561-564 - doi: 10.1111/jep.12936
- H Koffijberg & Saskia Knies (2018) - The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis. - Value in Health, 21 (2), 203-209 - doi: 10.1016/j.jval.2017.04.011
- Matthijs Versteegh, Saskia Knies & Werner Brouwer (2016) - From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare - Pharmacoeconomics (Print), 34 (11), 1071-1074 - doi: 10.1007/s40273-016-0431-y
- Olena Mandrik, Saskia Knies, O Golubovska, O Duda, L Dudar, S Fedorchenko, O Zaliska & Hans Severens (2015) - Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine - Open medicine, 10 (1), 25-33 - doi: 10.1515/med-2015-0006
- Olena Mandrik, Saskia Knies & Hans Severens (2015) - Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan - ClinicoEconomics and Outcome Research, 7, 347-356 - doi: 10.2147/CEOR.S79513
- Olena Mandrik, Isaac Corro Ramos, Saskia Knies, Maiwenn Al & Hans Severens (2015) - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine - Cancer Management and Research (online), 2015 (7), 279-289 - doi: 10.2147/CMAR.S79258
- Olena Mandrik, Saskia Knies, Z Kalo & Hans Severens (2015) - REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE - International Journal of Technology Assessment in Health Care, 31 (6), 434-441 - doi: 10.1017/S0266462315000677
- Saskia Knies, A Boonen & Hans Severens (2014) - Do the Washington Panel recommendations hold for Europe: inversigating the relation between quality of life versus work-status, absenteeism and presenteeism - BioMed Central, 12 (24) - doi: 10.1186/1478-7547-12-24
- Saskia Knies, A Boonen, MJJM Candel, SMAA Evers & Hans Severens (2013) - Compensation Mechanisms for Lost Productivity: A Comparison between Four European Countries - Value in Health, 16, 740-744 - doi: 10.1016/j.jval.2013.03.1624
- Saskia Knies, G Lombardi, M Commers, H-P Dauben, SMAA Evers, K Michelsen, W Oortwijn, C Opara & H (Hermann) Brand (2013) - Supporting decision making in cross-border regions: a health technology assessment tool for hospitals. - International Journal of Technology Assessment in Health Care, 29 (1), 71-78 - doi: 10.1017/S0266462312000785
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2012) - Lost Productivity in Four European Countries among Patients with Rheumatic Disorders - Pharmacoeconomics (Print), 30 (9), 795-807 - doi: 10.2165/11591520-000000000-00000
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2010) - Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable? - Pharmacoeconomics (Print), 30 (9), 795-807
- Saskia Knies, Hans Severens, AJHA Ament & SMAA Evers (2010) - The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines - Value in Health, 13 (5), 519-527
- Saskia Knies, AJHA Ament, SMAA Evers & Hans Severens (2009) - The transferability of economic evaluations. Testing the model of Welte - Value in Health, 12 (5), 730-738
- Saskia Knies, SMAA Evers, MJJM Candel, Hans Severens & AJHA Ament (2009) - Utilities of the EQ-5D: transferable or not? - Pharmacoeconomics (Print), 27 (9), 767-779
- TL (Talitha) Feenstra, Saskia Knies, BLT Ramaekers & H Koffijberg (2020) - Gezondheids-economische beslismodellen: de stand van zaken en de toekomst - VGE Bulletin, 24-27
- Rick A. Vreman, Joost W. Geenen, Saskia Knies, Aukje K. Mantel-Teeuwisse, Hubert G.M. Leufkens & Wim G. Goettsch (2021) - Comment on “Deterministic Sensitivity Analysis Under Ignorance” - PharmacoEconomics, 39 (10), 1199 - doi: 10.1007/s40273-021-01086-7
- Joost J. Enzing, Sebastian Himmler, Saskia Knies & Werner B.F. Brouwer (2021) - Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? - Value in Health - doi: 10.1016/j.jval.2021.08.007
- Joost Enzing, SMC Vijgen, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review - Health Policy and Technology - doi: 10.1016/j.hlpt.2020.09.006 - [link]
- Joost Enzing, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? - Health Economics, Policy and Law - doi: 10.1017/S1744133120000237 - [link]
- RA Vreman, JW Geenen, Saskia Knies, AK Mantel-Teeuwisse, HGM Leufkens & WG Goettsch (2020) - The Application and Implications of Novel Deterministic Sensitivity Analysis Methods. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-020-00979-3
- C Rothery, M Strong, HE Koffijberg, A Basu, S Ghabri, Saskia Knies, JF Murray, GD Sanders Schmidler, L Steuten & E Fenwick (2020) - Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (3), 277-286 - doi: 10.1016/j.jval.2020.01.004
- E Fenwick, L Steuten, Saskia Knies, S Ghabri, A Basu, JF Murray, HE Koffijberg, M Strong, GD Sanders Schmidler & C Rothery (2020) - Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (2), 139-150 - doi: 10.1016/j.jval.2020.01.001.
- SE Grimm, X Pouwels, BLT Ramaekers, B Wijnen, Saskia Knies, J Grutters & MA Joore (2019) - Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-019-00855-9.
- Saskia Knies, Hans Severens & Werner Brouwer (2019) - Integrating clinical and economic evidence in clinical guidelines: More needed than ever! - Journal of Evaluation in Clinical Practice, 25 (4), 561-564 - doi: 10.1111/jep.12936
- H Koffijberg & Saskia Knies (2018) - The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis. - Value in Health, 21 (2), 203-209 - doi: 10.1016/j.jval.2017.04.011
- Matthijs Versteegh, Saskia Knies & Werner Brouwer (2016) - From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare - Pharmacoeconomics (Print), 34 (11), 1071-1074 - doi: 10.1007/s40273-016-0431-y
- Olena Mandrik, Saskia Knies, O Golubovska, O Duda, L Dudar, S Fedorchenko, O Zaliska & Hans Severens (2015) - Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine - Open medicine, 10 (1), 25-33 - doi: 10.1515/med-2015-0006
- Olena Mandrik, Saskia Knies & Hans Severens (2015) - Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan - ClinicoEconomics and Outcome Research, 7, 347-356 - doi: 10.2147/CEOR.S79513
- Olena Mandrik, Isaac Corro Ramos, Saskia Knies, Maiwenn Al & Hans Severens (2015) - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine - Cancer Management and Research (online), 2015 (7), 279-289 - doi: 10.2147/CMAR.S79258
- Olena Mandrik, Saskia Knies, Z Kalo & Hans Severens (2015) - REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE - International Journal of Technology Assessment in Health Care, 31 (6), 434-441 - doi: 10.1017/S0266462315000677
- Saskia Knies, A Boonen & Hans Severens (2014) - Do the Washington Panel recommendations hold for Europe: inversigating the relation between quality of life versus work-status, absenteeism and presenteeism - BioMed Central, 12 (24) - doi: 10.1186/1478-7547-12-24
- Saskia Knies, A Boonen, MJJM Candel, SMAA Evers & Hans Severens (2013) - Compensation Mechanisms for Lost Productivity: A Comparison between Four European Countries - Value in Health, 16, 740-744 - doi: 10.1016/j.jval.2013.03.1624
- Saskia Knies, G Lombardi, M Commers, H-P Dauben, SMAA Evers, K Michelsen, W Oortwijn, C Opara & H (Hermann) Brand (2013) - Supporting decision making in cross-border regions: a health technology assessment tool for hospitals. - International Journal of Technology Assessment in Health Care, 29 (1), 71-78 - doi: 10.1017/S0266462312000785
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2012) - Lost Productivity in Four European Countries among Patients with Rheumatic Disorders - Pharmacoeconomics (Print), 30 (9), 795-807 - doi: 10.2165/11591520-000000000-00000
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2010) - Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable? - Pharmacoeconomics (Print), 30 (9), 795-807
- Saskia Knies, Hans Severens, AJHA Ament & SMAA Evers (2010) - The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines - Value in Health, 13 (5), 519-527
- Saskia Knies, AJHA Ament, SMAA Evers & Hans Severens (2009) - The transferability of economic evaluations. Testing the model of Welte - Value in Health, 12 (5), 730-738
- Saskia Knies, SMAA Evers, MJJM Candel, Hans Severens & AJHA Ament (2009) - Utilities of the EQ-5D: transferable or not? - Pharmacoeconomics (Print), 27 (9), 767-779
- TL (Talitha) Feenstra, Saskia Knies, BLT Ramaekers & H Koffijberg (2020) - Gezondheids-economische beslismodellen: de stand van zaken en de toekomst - VGE Bulletin, 24-27
- Joost J. Enzing, Sebastian Himmler, Saskia Knies & Werner B.F. Brouwer (2021) - Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? - Value in Health - doi: 10.1016/j.jval.2021.08.007
- Joost Enzing, SMC Vijgen, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review - Health Policy and Technology - doi: 10.1016/j.hlpt.2020.09.006 - [link]
- Joost Enzing, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? - Health Economics, Policy and Law - doi: 10.1017/S1744133120000237 - [link]
- RA Vreman, JW Geenen, Saskia Knies, AK Mantel-Teeuwisse, HGM Leufkens & WG Goettsch (2020) - The Application and Implications of Novel Deterministic Sensitivity Analysis Methods. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-020-00979-3
- C Rothery, M Strong, HE Koffijberg, A Basu, S Ghabri, Saskia Knies, JF Murray, GD Sanders Schmidler, L Steuten & E Fenwick (2020) - Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (3), 277-286 - doi: 10.1016/j.jval.2020.01.004
- E Fenwick, L Steuten, Saskia Knies, S Ghabri, A Basu, JF Murray, HE Koffijberg, M Strong, GD Sanders Schmidler & C Rothery (2020) - Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (2), 139-150 - doi: 10.1016/j.jval.2020.01.001.
- SE Grimm, X Pouwels, BLT Ramaekers, B Wijnen, Saskia Knies, J Grutters & MA Joore (2019) - Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-019-00855-9.
- Saskia Knies, Hans Severens & Werner Brouwer (2019) - Integrating clinical and economic evidence in clinical guidelines: More needed than ever! - Journal of Evaluation in Clinical Practice, 25 (4), 561-564 - doi: 10.1111/jep.12936
- H Koffijberg & Saskia Knies (2018) - The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis. - Value in Health, 21 (2), 203-209 - doi: 10.1016/j.jval.2017.04.011
- Matthijs Versteegh, Saskia Knies & Werner Brouwer (2016) - From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare - Pharmacoeconomics (Print), 34 (11), 1071-1074 - doi: 10.1007/s40273-016-0431-y
- Olena Mandrik, Saskia Knies, O Golubovska, O Duda, L Dudar, S Fedorchenko, O Zaliska & Hans Severens (2015) - Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine - Open medicine, 10 (1), 25-33 - doi: 10.1515/med-2015-0006
- Olena Mandrik, Saskia Knies & Hans Severens (2015) - Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan - ClinicoEconomics and Outcome Research, 7, 347-356 - doi: 10.2147/CEOR.S79513
- Olena Mandrik, Isaac Corro Ramos, Saskia Knies, Maiwenn Al & Hans Severens (2015) - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine - Cancer Management and Research (online), 2015 (7), 279-289 - doi: 10.2147/CMAR.S79258
- Olena Mandrik, Saskia Knies, Z Kalo & Hans Severens (2015) - REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE - International Journal of Technology Assessment in Health Care, 31 (6), 434-441 - doi: 10.1017/S0266462315000677
- Saskia Knies, A Boonen & Hans Severens (2014) - Do the Washington Panel recommendations hold for Europe: inversigating the relation between quality of life versus work-status, absenteeism and presenteeism - BioMed Central, 12 (24) - doi: 10.1186/1478-7547-12-24
- Saskia Knies, A Boonen, MJJM Candel, SMAA Evers & Hans Severens (2013) - Compensation Mechanisms for Lost Productivity: A Comparison between Four European Countries - Value in Health, 16, 740-744 - doi: 10.1016/j.jval.2013.03.1624
- Saskia Knies, G Lombardi, M Commers, H-P Dauben, SMAA Evers, K Michelsen, W Oortwijn, C Opara & H (Hermann) Brand (2013) - Supporting decision making in cross-border regions: a health technology assessment tool for hospitals. - International Journal of Technology Assessment in Health Care, 29 (1), 71-78 - doi: 10.1017/S0266462312000785
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2012) - Lost Productivity in Four European Countries among Patients with Rheumatic Disorders - Pharmacoeconomics (Print), 30 (9), 795-807 - doi: 10.2165/11591520-000000000-00000
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2010) - Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable? - Pharmacoeconomics (Print), 30 (9), 795-807
- Saskia Knies, Hans Severens, AJHA Ament & SMAA Evers (2010) - The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines - Value in Health, 13 (5), 519-527
- Saskia Knies, AJHA Ament, SMAA Evers & Hans Severens (2009) - The transferability of economic evaluations. Testing the model of Welte - Value in Health, 12 (5), 730-738
- Saskia Knies, SMAA Evers, MJJM Candel, Hans Severens & AJHA Ament (2009) - Utilities of the EQ-5D: transferable or not? - Pharmacoeconomics (Print), 27 (9), 767-779
- Joost J. Enzing, Sebastian Himmler, Saskia Knies & Werner B.F. Brouwer (2021) - Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? - Value in Health - doi: 10.1016/j.jval.2021.08.007
- Joost Enzing, SMC Vijgen, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Do economic evaluations of TAVI deal with learning effects, innovation, and context dependency? A review - Health Policy and Technology - doi: 10.1016/j.hlpt.2020.09.006 - [link]
- Joost Enzing, Saskia Knies, Bert Boer & Werner Brouwer (2020) - Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? - Health Economics, Policy and Law - doi: 10.1017/S1744133120000237 - [link]
- RA Vreman, JW Geenen, Saskia Knies, AK Mantel-Teeuwisse, HGM Leufkens & WG Goettsch (2020) - The Application and Implications of Novel Deterministic Sensitivity Analysis Methods. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-020-00979-3
- C Rothery, M Strong, HE Koffijberg, A Basu, S Ghabri, Saskia Knies, JF Murray, GD Sanders Schmidler, L Steuten & E Fenwick (2020) - Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (3), 277-286 - doi: 10.1016/j.jval.2020.01.004
- E Fenwick, L Steuten, Saskia Knies, S Ghabri, A Basu, JF Murray, HE Koffijberg, M Strong, GD Sanders Schmidler & C Rothery (2020) - Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. - Value in Health, 23 (2), 139-150 - doi: 10.1016/j.jval.2020.01.001.
- SE Grimm, X Pouwels, BLT Ramaekers, B Wijnen, Saskia Knies, J Grutters & MA Joore (2019) - Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. - Pharmacoeconomics (Print) - doi: 10.1007/s40273-019-00855-9.
- Saskia Knies, Hans Severens & Werner Brouwer (2019) - Integrating clinical and economic evidence in clinical guidelines: More needed than ever! - Journal of Evaluation in Clinical Practice, 25 (4), 561-564 - doi: 10.1111/jep.12936
- H Koffijberg & Saskia Knies (2018) - The Impact of Decision Makers' Constraints on the Outcome of Value of Information Analysis. - Value in Health, 21 (2), 203-209 - doi: 10.1016/j.jval.2017.04.011
- Matthijs Versteegh, Saskia Knies & Werner Brouwer (2016) - From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare - Pharmacoeconomics (Print), 34 (11), 1071-1074 - doi: 10.1007/s40273-016-0431-y
- Olena Mandrik, Saskia Knies, O Golubovska, O Duda, L Dudar, S Fedorchenko, O Zaliska & Hans Severens (2015) - Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine - Open medicine, 10 (1), 25-33 - doi: 10.1515/med-2015-0006
- Olena Mandrik, Saskia Knies & Hans Severens (2015) - Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan - ClinicoEconomics and Outcome Research, 7, 347-356 - doi: 10.2147/CEOR.S79513
- Olena Mandrik, Isaac Corro Ramos, Saskia Knies, Maiwenn Al & Hans Severens (2015) - Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine - Cancer Management and Research (online), 2015 (7), 279-289 - doi: 10.2147/CMAR.S79258
- Olena Mandrik, Saskia Knies, Z Kalo & Hans Severens (2015) - REVIEWING TRANSFERABILITY IN ECONOMIC EVALUATIONS ORIGINATING FROM EASTERN EUROPE - International Journal of Technology Assessment in Health Care, 31 (6), 434-441 - doi: 10.1017/S0266462315000677
- Saskia Knies, A Boonen & Hans Severens (2014) - Do the Washington Panel recommendations hold for Europe: inversigating the relation between quality of life versus work-status, absenteeism and presenteeism - BioMed Central, 12 (24) - doi: 10.1186/1478-7547-12-24
- Saskia Knies, A Boonen, MJJM Candel, SMAA Evers & Hans Severens (2013) - Compensation Mechanisms for Lost Productivity: A Comparison between Four European Countries - Value in Health, 16, 740-744 - doi: 10.1016/j.jval.2013.03.1624
- Saskia Knies, G Lombardi, M Commers, H-P Dauben, SMAA Evers, K Michelsen, W Oortwijn, C Opara & H (Hermann) Brand (2013) - Supporting decision making in cross-border regions: a health technology assessment tool for hospitals. - International Journal of Technology Assessment in Health Care, 29 (1), 71-78 - doi: 10.1017/S0266462312000785
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2012) - Lost Productivity in Four European Countries among Patients with Rheumatic Disorders - Pharmacoeconomics (Print), 30 (9), 795-807 - doi: 10.2165/11591520-000000000-00000
- Saskia Knies, MJJM Candel, A Boonen, SMAA Evers, AJHA Ament & Hans Severens (2010) - Lost productivity in four European countries among patients with rheumatic disorders: are absenteeism and presenteeism transferable? - Pharmacoeconomics (Print), 30 (9), 795-807
- Saskia Knies, Hans Severens, AJHA Ament & SMAA Evers (2010) - The Transferability of Valuing Lost Productivity across Jurisdictions. Differences between National Pharmacoeconomic Guidelines - Value in Health, 13 (5), 519-527
- Saskia Knies, AJHA Ament, SMAA Evers & Hans Severens (2009) - The transferability of economic evaluations. Testing the model of Welte - Value in Health, 12 (5), 730-738
- Saskia Knies, SMAA Evers, MJJM Candel, Hans Severens & AJHA Ament (2009) - Utilities of the EQ-5D: transferable or not? - Pharmacoeconomics (Print), 27 (9), 767-779
- TL (Talitha) Feenstra, Saskia Knies, BLT Ramaekers & H Koffijberg (2020) - Gezondheids-economische beslismodellen: de stand van zaken en de toekomst - VGE Bulletin, 24-27
- TL (Talitha) Feenstra, Saskia Knies, BLT Ramaekers & H Koffijberg (2020) - Gezondheids-economische beslismodellen: de stand van zaken en de toekomst - VGE Bulletin, 24-27
- Rick A. Vreman, Joost W. Geenen, Saskia Knies, Aukje K. Mantel-Teeuwisse, Hubert G.M. Leufkens & Wim G. Goettsch (2021) - Comment on “Deterministic Sensitivity Analysis Under Ignorance” - PharmacoEconomics, 39 (10), 1199 - doi: 10.1007/s40273-021-01086-7
- Rick A. Vreman, Joost W. Geenen, Saskia Knies, Aukje K. Mantel-Teeuwisse, Hubert G.M. Leufkens & Wim G. Goettsch (2021) - Comment on “Deterministic Sensitivity Analysis Under Ignorance” - PharmacoEconomics, 39 (10), 1199 - doi: 10.1007/s40273-021-01086-7